SCHEMBL4658937

SCHEMBL4658937

CC(C)(C)OC(=O)ON1CCN(C2(C)CCN(Cc3ccccc3)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPFFR1 Q9GZQ6 1/20 0.47
NPFFR2 Q9Y5X5 1/20 0.47
CYP2D6 P10635 6/20 0.45
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
USP2 O75604 1/20 0.42
MAPK1 P28482 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM3 P20309 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
P4HB P07237 1/20 0.41
CCR5 P51681 1/20 0.41
OPRL1 P41146 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
OPRM1 P35372 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1207130 0.84 OPRD1 (0.53) NPFFR1NPFFR2CYP2D6ALDH1A1CYP3A4
SCHEMBL4717872 0.77 SMN1; SMN2 (0.51) ALDH1A1
SCHEMBL2158292 0.77 DRD2 (0.53) NPFFR1NPFFR2CYP2D6TSHRALDH1A1
SCHEMBL27524788 0.75 SIGMAR1 (0.53) ALDH1A1SIGMAR1POLB
SCHEMBL3395200 0.75 GRIN2B (0.47) L3MBTL1
SCHEMBL4658746 0.74 KDM4E (0.31) ALDH1A1CYP3A4CYP2C9CYP2C19L3MBTL1
SCHEMBL31334693 0.74 NPFFR1 (0.53) NPFFR1NPFFR2CYP2D6TSHRALDH1A1
SCHEMBL14722834 0.74 NPFFR1 (0.50) NPFFR1NPFFR2CYP2D6TSHRALDH1A1
SCHEMBL1997960 0.74 NPFFR1 (0.58) NPFFR1NPFFR2CYP2D6ALDH1A1CYP3A4
SCHEMBL2085642 0.73 MC4R (0.69) NPFFR1NPFFR2CYP2D6TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917256-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2008-05-07 EP disclosed
WO-2007020261-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 WO disclosed